| Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines M Najlah, A Kadam, KW Wan, W Ahmed, KMG Taylor, AMA Elhissi International Journal of Pharmaceutics 506 (1-2), 102-109, 2016 | 60 | 2016 |
| Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature AN Kadam, M Najlah, KW Wan, W Ahmed, SJ Crean, DA Phoenix, ... Pharmaceutical Development and Technology 19 (8), 999-1004, 2014 | 35 | 2014 |
| Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature CF Cho, L Yu, TK Nsiama, AN Kadam, A Raturi, S Shukla, GA Amadei, ... Nanoscale 9 (33), 12096-12109, 2017 | 31 | 2017 |
| EGFL7 inhibits tumor angiogenesis via its Emilin-like domain A Kadam | | 2017 |
| A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin-and thrombospondin-dependent manner CF Cho, LA Fung, T Nsiama, L Yu, A Kadam, DF Quail, ... Cancer Research 74 (19_Supplement), 4812-4812, 2014 | | 2014 |
| Nanoemulsion formulations for brain tumour therapy AN Kadam University of Central Lancashire, 2013 | | 2013 |
| PACLITAXEL LOADED LIPID NANOEMULSIONS FOR THE TREATMENT OF BRAIN TUMOUR M Najlah, A Kadam, KW Wan, W Ahmed, A Elhissi | | |
